NCT05416931View on ClinicalTrials.gov

ACD440 Gel in Peripheral Neuropathic Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

March 10, 2023

Study Completion Date

March 10, 2023

Conditions

Peripheral Neuropathic Pain

Interventions

DRUG

ACD440 Gel 14mg/g

Topical application to painful area

DRUG

Placebo Gel

Topical application to painful area

Trial Locations (1)

75185

Akademiska sjukhuset, Uppsala

Sponsors

Lead Sponsor

AlzeCure Pharma

All Listed Sponsors

lead

AlzeCure Pharma

INDUSTRY

NCT05416931 - ACD440 Gel in Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter